GFP/Luc Reporter Cell Line - KYSE-510

KYSE-510 is a human esophageal squamous cell carcinoma (ESCC) cell line established from a primary esophageal tumor and is widely used in studies of esophageal cancer biology and therapeutic development. As a representative ESCC model, KYSE-510 exhibits molecular and phenotypic characteristics associated with aggressive squamous cell carcinoma, including enhanced proliferative capacity and invasive behavior. The cell line has been extensively utilized to investigate mechanisms underlying tumor progression, metastasis, therapeutic resistance, and oncogenic signaling in esophageal cancer. The GFP/Luc Reporter Cell Line - KYSE-510 is generated through stable transduction of green fluorescent protein (GFP) and firefly luciferase (Luc) reporter genes into parental KYSE-510 cells. This dual-reporter system enables simultaneous fluorescence-based visualization and quantitative bioluminescence imaging while maintaining the essential biological properties and tumorigenic potential of the original cell line.

The KYSE-510-GFP/Luc reporter cell line is broadly applied in esophageal cancer research for both in vitro functional studies and in vivo tumor modeling. Luciferase expression enables sensitive, non-invasive monitoring of tumor growth, metastatic dissemination, and therapeutic response through longitudinal bioluminescence imaging in xenograft models. GFP expression facilitates direct visualization of cellular morphology, proliferation, migration, and tissue distribution in cultured cells and excised tumor specimens. This model is particularly valuable for evaluating chemotherapeutic agents, molecularly targeted therapies, radiotherapy sensitizers, and emerging combination treatment strategies for esophageal squamous cell carcinoma. In addition, the dual-reporter platform supports mechanistic studies of epithelial–mesenchymal transition, tumor microenvironment interactions, cancer stem cell-associated traits, and signaling pathways involved in invasion and metastasis. Owing to its stable reporter expression and reproducible imaging performance, the KYSE-510-GFP/Luc cell line provides a robust and reliable tool for preclinical drug screening, therapeutic efficacy assessment, and translational research in esophageal cancer.